Get the Stockscreener App
0.51
4.72%
0.023
Xtant Medical Holdings Inc stock is traded at $0.51, with a volume of 79,203.
It is up +4.72% in the last 24 hours and down -14.57% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.487
Open:
$0.48
24h Volume:
79,203
Relative Volume:
0.65
Market Cap:
$70.92M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
51.00
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
+5.72%
1M Performance:
-14.57%
6M Performance:
-11.54%
1Y Performance:
-54.46%
1-Day Range:
$0.44
$0.51
1-Week Range:
$0.43
$0.51
52-Week Range:
$0.331
$1.24
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.51 | 70.92M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Faces Risk of Share Distribution by Major Stakeholder, Threatening Stock Stability - MSN
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2024 Earnings Call Transcript - Insider Monkey
Xtant Medical’s Earnings Call: Mixed Outlook with Growth Plans - TipRanks
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops - Investing.com India
Earnings call transcript: Xtant Medical Q4 2024 misses EPS, stock drops By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating By Investing.com - Investing.com South Africa
Xtant Medical stock target cut to $2 at BTIG, retains buy rating - Investing.com
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update - Defense World
Xtant Medical Reports Strong 2024 Revenue Growth - TipRanks
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025 - Yahoo Finance
When Will Xtant Medical Reveal Its 2024 Performance? Key Date for Spinal Tech Investors - StockTitan
Investor Network: Xtant Medical Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Xtant Medical (NYSEAMERICAN:XTNT) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Drop in Short Interest - MarketBeat
Xtant Medical Holdings Inc (AMEX: XTNT) – An Analysis Is What You Need - Stocks Register
Xtant Medical (NYSEAMERICAN:XTNT) Shares Pass Above 200-Day Moving AverageHere's What Happened - MarketBeat
Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200 Day Moving Average – Should You Sell? - Defense World
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Significant Growth in Short Interest - MarketBeat
US Penny Stocks To Watch In January 2025 - Simply Wall St
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Xtant Medical (NYSEAMERICAN:XTNT) Shares Pass Above 200-Day Moving Average – Here’s Why - Defense World
Xtant Medical Holdings, Inc. Announces Board Changes -August 24, 2022 at 08:16 am EDT - Marketscreener.com
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Increase in Short Interest - MarketBeat
Geode Capital Management LLC Purchases 212,394 Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) - Defense World
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Xtant Medical Expands Product Portfolio with Launch of its own V - GuruFocus.com
Xtant Medical Holdings, Inc. announced that it expects to receive $9.746606 million in funding - Marketscreener.com
3 US Penny Stocks With Market Caps Under $300M - Simply Wall St
Xtant Medical (NYSEAMERICAN:XTNT) Stock Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Xtant Medical (NYSEAMERICAN:XTNT) Shares Pass Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Xtant Medical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Global Spinal Allografts Market Analysis 2024–2032: Trends, Growth Drivers, Challenges, and Data-Driven Insights - WICZ
Xtant Medical (NYSEAMERICAN:XTNT) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Earnings call: Xtant Medical announces revenue growth in Q3 2024 - Investing.com
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q3 2024 Earnings Call Transcript - Insider Monkey
Xtant Medical Reports Q3 2024 Revenue Growth and New Product Launches - TipRanks
Xtant Medical Reports Third Quarter 2024 Financial Results - Yahoo Finance
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):